Maternal Cardiac Assessment at 35 to 37 Weeks Improves Prediction of Development of Preeclampsia

Coral Garcia-Gonzalez; Georgios Georgiopoulos; Samira Abdel Azim; Fernando Macaya; Nikos Kametas; Petros Nihoyannopoulos; Kypros H. Nicolaides; Marietta Charakida

doi:10.1161/HYPERTENSIONAHA.120.14643

Maternal Cardiac Assessment at 35 to 37 Weeks Improves Prediction of Development of Preeclampsia

Coral Garcia-Gonzalez, Georgios Georgiopoulos, Samira Abdel Azim, Fernando Macaya, Nikos Kametas, Petros Nihoyannopoulos, Kypros H. Nicolaides^*, Marietta Charakida

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

11 Citations (Scopus)

Abstract

Preeclampsia at term accounts for half of maternal deaths from hypertensive disorders. We aimed to assess differences in maternal cardiac indices at 35⁺⁰to 36⁺⁶weeks' gestation between women who subsequently developed preeclampsia at term compared with those with uncomplicated pregnancy and to evaluate whether cardiac indices offer incremental prognostic value to the available screening algorithm for preeclampsia. We recruited 1602 women with singleton pregnancies who attended for a routine hospital visit at 35⁺⁰to 36⁺⁶weeks' gestation between April and November 2018. We recorded maternal characteristics and preeclampsia-risk-score derived from a competing risks model and measured cardiac indices. Preeclampsia developed in 3.12% (50/1602) of participants. Women with preeclampsia, compared with those without, had increased mean arterial pressure (97.6, SD, 5.53 versus 87.9, SD, 6.82 mm Hg), systemic vascular resistance (1500, interquartile range, 1393-1831 versus 1400, interquartile range, 1202-1630 PRU) and preeclampsia-risk-score (23.4, interquartile range, 9.13-40 versus 0.9, interquartile range, 0.32-3.25). Multivariable analysis demonstrated independent association between the incidence of preeclampsia and E/e′ (hazard ratio, 1.19/unit [95% CI, 1.03-1.37]; P=0.018) as well as left ventricular mass indexed for body surface area (hazard ratio, 1.03/[g·m²] [95% CI, 1.003-1.051]; P=0.029). Women with E/e′ ≥7.3 and left ventricular mass indexed for body surface area ≥63.2 g/m²had an increased risk for developing preeclampsia, despite low preeclampsia-risk-score <5% (hazard ratio, 20.1 [95% CI, 10.5-38.7], P<0.001). Increased left ventricular mass and E/e′ offer incremental information to available scoring systems and better stratify women at risk of developing preeclampsia at term.

Original language	English
Pages (from-to)	514-522
Number of pages	9
Journal	Hypertension
DOIs	https://doi.org/10.1161/HYPERTENSIONAHA.120.14643
Publication status	Accepted/In press - 1 Jan 2020

Keywords

diastolic function
morbidity
mortality
preeclampsia
pregnancy

Access to Document

10.1161/HYPERTENSIONAHA.120.14643

Cite this

@article{48728b0c676c4a7a8939d57604c35356,

title = "Maternal Cardiac Assessment at 35 to 37 Weeks Improves Prediction of Development of Preeclampsia",

abstract = "Preeclampsia at term accounts for half of maternal deaths from hypertensive disorders. We aimed to assess differences in maternal cardiac indices at 35+0to 36+6weeks' gestation between women who subsequently developed preeclampsia at term compared with those with uncomplicated pregnancy and to evaluate whether cardiac indices offer incremental prognostic value to the available screening algorithm for preeclampsia. We recruited 1602 women with singleton pregnancies who attended for a routine hospital visit at 35+0to 36+6weeks' gestation between April and November 2018. We recorded maternal characteristics and preeclampsia-risk-score derived from a competing risks model and measured cardiac indices. Preeclampsia developed in 3.12% (50/1602) of participants. Women with preeclampsia, compared with those without, had increased mean arterial pressure (97.6, SD, 5.53 versus 87.9, SD, 6.82 mm Hg), systemic vascular resistance (1500, interquartile range, 1393-1831 versus 1400, interquartile range, 1202-1630 PRU) and preeclampsia-risk-score (23.4, interquartile range, 9.13-40 versus 0.9, interquartile range, 0.32-3.25). Multivariable analysis demonstrated independent association between the incidence of preeclampsia and E/e′ (hazard ratio, 1.19/unit [95% CI, 1.03-1.37]; P=0.018) as well as left ventricular mass indexed for body surface area (hazard ratio, 1.03/[g·m2] [95% CI, 1.003-1.051]; P=0.029). Women with E/e′ ≥7.3 and left ventricular mass indexed for body surface area ≥63.2 g/m2had an increased risk for developing preeclampsia, despite low preeclampsia-risk-score <5% (hazard ratio, 20.1 [95% CI, 10.5-38.7], P<0.001). Increased left ventricular mass and E/e′ offer incremental information to available scoring systems and better stratify women at risk of developing preeclampsia at term.",

keywords = "diastolic function, morbidity, mortality, preeclampsia, pregnancy",

author = "Coral Garcia-Gonzalez and Georgios Georgiopoulos and Azim, {Samira Abdel} and Fernando Macaya and Nikos Kametas and Petros Nihoyannopoulos and Nicolaides, {Kypros H.} and Marietta Charakida",

year = "2020",

month = jan,

day = "1",

doi = "10.1161/HYPERTENSIONAHA.120.14643",

language = "English",

pages = "514--522",

journal = "Hypertension (Dallas, Tex. : 1979)",

issn = "0194-911X",

publisher = "American Heart Association",

}

TY - JOUR

T1 - Maternal Cardiac Assessment at 35 to 37 Weeks Improves Prediction of Development of Preeclampsia

AU - Garcia-Gonzalez, Coral

AU - Georgiopoulos, Georgios

AU - Azim, Samira Abdel

AU - Macaya, Fernando

AU - Kametas, Nikos

AU - Nihoyannopoulos, Petros

AU - Nicolaides, Kypros H.

AU - Charakida, Marietta

PY - 2020/1/1

Y1 - 2020/1/1

N2 - Preeclampsia at term accounts for half of maternal deaths from hypertensive disorders. We aimed to assess differences in maternal cardiac indices at 35+0to 36+6weeks' gestation between women who subsequently developed preeclampsia at term compared with those with uncomplicated pregnancy and to evaluate whether cardiac indices offer incremental prognostic value to the available screening algorithm for preeclampsia. We recruited 1602 women with singleton pregnancies who attended for a routine hospital visit at 35+0to 36+6weeks' gestation between April and November 2018. We recorded maternal characteristics and preeclampsia-risk-score derived from a competing risks model and measured cardiac indices. Preeclampsia developed in 3.12% (50/1602) of participants. Women with preeclampsia, compared with those without, had increased mean arterial pressure (97.6, SD, 5.53 versus 87.9, SD, 6.82 mm Hg), systemic vascular resistance (1500, interquartile range, 1393-1831 versus 1400, interquartile range, 1202-1630 PRU) and preeclampsia-risk-score (23.4, interquartile range, 9.13-40 versus 0.9, interquartile range, 0.32-3.25). Multivariable analysis demonstrated independent association between the incidence of preeclampsia and E/e′ (hazard ratio, 1.19/unit [95% CI, 1.03-1.37]; P=0.018) as well as left ventricular mass indexed for body surface area (hazard ratio, 1.03/[g·m2] [95% CI, 1.003-1.051]; P=0.029). Women with E/e′ ≥7.3 and left ventricular mass indexed for body surface area ≥63.2 g/m2had an increased risk for developing preeclampsia, despite low preeclampsia-risk-score <5% (hazard ratio, 20.1 [95% CI, 10.5-38.7], P<0.001). Increased left ventricular mass and E/e′ offer incremental information to available scoring systems and better stratify women at risk of developing preeclampsia at term.

AB - Preeclampsia at term accounts for half of maternal deaths from hypertensive disorders. We aimed to assess differences in maternal cardiac indices at 35+0to 36+6weeks' gestation between women who subsequently developed preeclampsia at term compared with those with uncomplicated pregnancy and to evaluate whether cardiac indices offer incremental prognostic value to the available screening algorithm for preeclampsia. We recruited 1602 women with singleton pregnancies who attended for a routine hospital visit at 35+0to 36+6weeks' gestation between April and November 2018. We recorded maternal characteristics and preeclampsia-risk-score derived from a competing risks model and measured cardiac indices. Preeclampsia developed in 3.12% (50/1602) of participants. Women with preeclampsia, compared with those without, had increased mean arterial pressure (97.6, SD, 5.53 versus 87.9, SD, 6.82 mm Hg), systemic vascular resistance (1500, interquartile range, 1393-1831 versus 1400, interquartile range, 1202-1630 PRU) and preeclampsia-risk-score (23.4, interquartile range, 9.13-40 versus 0.9, interquartile range, 0.32-3.25). Multivariable analysis demonstrated independent association between the incidence of preeclampsia and E/e′ (hazard ratio, 1.19/unit [95% CI, 1.03-1.37]; P=0.018) as well as left ventricular mass indexed for body surface area (hazard ratio, 1.03/[g·m2] [95% CI, 1.003-1.051]; P=0.029). Women with E/e′ ≥7.3 and left ventricular mass indexed for body surface area ≥63.2 g/m2had an increased risk for developing preeclampsia, despite low preeclampsia-risk-score <5% (hazard ratio, 20.1 [95% CI, 10.5-38.7], P<0.001). Increased left ventricular mass and E/e′ offer incremental information to available scoring systems and better stratify women at risk of developing preeclampsia at term.

KW - diastolic function

KW - morbidity

KW - mortality

KW - preeclampsia

KW - pregnancy

UR - http://www.scopus.com/inward/record.url?scp=85087900779&partnerID=8YFLogxK

U2 - 10.1161/HYPERTENSIONAHA.120.14643

DO - 10.1161/HYPERTENSIONAHA.120.14643

M3 - Article

C2 - 32564692

AN - SCOPUS:85087900779

SN - 0194-911X

SP - 514

EP - 522

JO - Hypertension (Dallas, Tex. : 1979)

JF - Hypertension (Dallas, Tex. : 1979)

ER -

Maternal Cardiac Assessment at 35 to 37 Weeks Improves Prediction of Development of Preeclampsia

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this